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The Centers for Disease Control and
Prevention (CDC) describes its own mission
as serving “as the national focus for develop-
ing and applying disease prevention and
control, environmental health, and health
promotion and education activities designed
to improve the health of the people of the
United States” (CDC 2005). Recently, the
CDC, for the first time, funded state and
larger metropolitan health departments and
three academic centers to begin to develop a
national environmental public health tracking
(EPHT) network. The CDC vision for the
EPHT program is to improve protection of
communities from adverse health effects
through the integration of public health and
environmental information systems. To
implement this vision, the goal is to develop a
national tracking (i.e., surveillance) network
that links chronic disease and environmental
data sources.
Surveillance has a long tradition in public
health for both the descriptive epidemiology
of diseases and the provision of insights into
disease causation and disease control. It can
be taken as axiomatic that, ultimately, all
surveillance systems aim at disease control.
Generally, surveillance refers to the continu-
ous, routine collection of data related to
health or exposures of populations over the
long term, and the associated analysis, inter-
pretation, and dissemination of the results.
Surveillance data collected by government
agencies such as the CDC and the U.S.
Environmental Protection Agency (EPA) pro-
vide important archives that permit contin-
ued reinterpretation and health research. To
date, however, the data systems established
and used for surveillance focus either on
diseases/syndromes or on media (e.g., ambi-
ent air pollutants, toxic agents) without for-
mal linkage between systems. In this article,
we focus our analyses mainly on properties
and lessons learned from disease surveillance
systems. We also provide arguments that
effective surveillance does not always require
formal linkage of exposure and health out-
come data; indeed, there are problems inher-
ent in surveillance of environmentally related
diseases when based on formal linkage of
routinely collected data.
Established Surveillance
Systems—History, Goals, and
Properties
Surveillance for various specific diseases and
toxic agents has become an established feature
of public health systems in developed coun-
tries. The systems include sophisticated reg-
istries and monitoring networks that collect
data through several different techniques.
The oldest systems that allowed monitoring
of population health trends are vital statistic
records established in Europe in the 1700s.
In England and Wales, death records had a
prominent place as demographic barometers
for the health of communities and citizens
throughout the 19th century. Variations in
mortality rates from diseases such as cholera,
dysentery, or workplace-related death (e.g., due
to mining accidents) suggested socioeconomic,
work-related, and environmental causes. This
information was employed to justify a public
health campaign not only to improve popula-
tion health in England but also to measure the
success of interventions [e.g., the construction
of sewer systems (Mooney 1997)]. A distin-
guishing property of these early surveillance sys-
tems was a focus on acute causes of death for
which there were either close temporal and/or
spatial proximity between a perceived exposure
and the outcome sufﬁcient to establish causality
(Koch, in press); or they allowed broad ecologi-
cal comparisons of mortality rates between
communities before and after public health
interventions were implemented.
Vital statistics data (deaths, birth num-
bers, and outcomes) still provide a major
source of surveillance data to monitor and to
compare general trends in population health,
to identify subgroups at risk, and to assess the
effectiveness of intervention and treatment
programs. Moreover, developed nations have
invested in the establishment of many registry
systems to collect more detailed morbidity
data that provide surveillance for acute and
chronic infectious diseases, occupational
injuries and deaths, cancers, and birth defects.
Unfortunately, in the United States none of
the health outcomes surveillance databases are
linked specifically, in either space or time,
with relevant exposure databases.
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Disease surveillance has a century-long tradition in public health, and environmental data have
been collected at a national level by the U.S. Environmental Protection Agency for several decades.
Recently, the Centers for Disease Control and Prevention announced an initiative to develop
a national environmental public health tracking (EPHT) network with “linkage” of existing
environmental and chronic disease data as a central goal. On the basis of experience with long-
established disease surveillance systems, in this article we suggest how a system capable of linking
routinely collected disease and exposure data should be developed, but caution that formal linkage
of data is not the only approach required for an effective EPHT program. The primary opera-
tional goal of EPHT has to be the “treatment” of the environment to prevent and/or reduce expo-
sures and minimize population risk for developing chronic diseases. Chronic, multifactorial
diseases do not lend themselves to data-driven evaluations of intervention strategies, time trends,
exposure patterns, or identiﬁcation of at-risk populations based only on routinely collected surveil-
lance data. Thus, EPHT should be synonymous with a dynamic process requiring regular system
updates to a) incorporate new technologies to improve population-level exposure and disease
assessment, b) allow public dissemination of new data that become available, c) allow the policy
community to address new and emerging exposures and disease “threads,” and d) evaluate the
effectiveness of EPHT over some appropriate time interval. It will be necessary to weigh the bene-
ﬁts of surveillance against its costs, but the major challenge will be to maintain support for this
important new system. Key words: environmental health, evaluation, intervention, registries, sur-
veillance. Environ Health Perspect 113:243–249 (2005). doi:10.1289/ehp.7450 available via
http://dx.doi.org/ [Online 2 December 2004]
Research CommentaryBelow we describe the function, motiva-
tion, and attributes that make these systems
successful.
Surveillance for infectious and other acute
diseases. Infectious disease surveillance is the
paradigm for the surveillance of diseases that,
aside from some exceptions (e.g., syphilis,
tuberculosis, and AIDS), are characterized by
acute onset and rapid resolution. The descrip-
tive data provided by surveillance systems for
these types of diseases provide the basis for the
monitoring of the effects of interventions (e.g.,
standardized treatment, public education cam-
paigns) and temporal and spatial trends that
reﬂect changes in population behavior and atti-
tudes, demography, provision of health services
related to sexually transmitted diseases, and loss
of efﬁcacy of standard treatment regimens. The
detection of “outbreaks” of disease [e.g., resur-
gence of syphilis in populations of homosexual
males (D’Souza et al. 2003)] is an integral part
of these systems. The timely collection, organi-
zation, analysis, and dissemination of these
data facilitate prompt responses by public
health systems to changes in disease occurrence
for which immediate intervention appears war-
ranted. The CDC’s critical role in the control
of infectious diseases depends, to a large extent,
on data from these surveillance systems. For
these efforts to succeed, highly specific and
rapid methods for recognition and unambigu-
ous diagnosis of diseases, coupled with effective
and acceptable intervention strategies, must be
available. Many acute infectious diseases fulﬁll
these requirements. Continued technological
advances can be expected to improve still fur-
ther the diagnostic speed for other infectious
diseases that require longer diagnostic con-
firmation periods, such as tuberculosis and
AIDS. Intervention strategies to stop outbreaks
are varied and include a) treatment of the
infected individual, which results in both the
recovery of the affected individual and the pro-
tection of susceptible individuals in the popula-
tion from transmission, and b) if no treatment
is available, quarantine of the infected individ-
ual until remission and immunization of sus-
ceptible individuals—that is, by prevention of
transmission of the infectious agent and disease
through the removal of susceptible individuals
or carriers. Surveillance of diseases for which
we routinely immunize continues for the pur-
pose of identiﬁcation of gaps in immunity in a
population.
Infectious diseases of more insidious onset
and/or tendency to relapse and remit over long
periods of time (e.g., tuberculosis, HIV infec-
tion, malaria, Helicobacter pylori) pose prob-
lems for surveillance and characterize many of
the chronic diseases that would be the target
for environmental health tracking. Although
the speciﬁc pathogens can be identiﬁed with
relative ease, the diseases can present slowly
over long periods, such that the connection
between the primary exposure sources is lost
or difﬁcult to trace with speciﬁcity. Treatment
usually is long and burdensome, and methods
for primary prevention may be difficult or
impossible to implement (in terms of cost,
acceptability, and need for persistence). For
example, to control malaria, one has to prevent
transmission of the disease (vector control and
behavior change) rather than control the dis-
ease after transmission has occurred. Because
responses for these programs do not curb the
occurrence of proximal cases, the success of
these interventions will often not be apparent
until after a lengthy period during which no
new cases are observed. In fact, in cases where
there are long delays between the implementa-
tion of an intervention and the reduction in
disease incidence or morbidity, it may be difﬁ-
cult to quantitate precisely (or even accurately)
the extent to which the intervention altered the
outcome of the disease.
To complicate matters further, there are a
number of infectious agents that, to date, elude
our diagnostic and surveillance tools. Many
viruses and bacteria cause nonspecific syn-
dromes or symptom complexes that include
most diarrheal and respiratory symptoms. The
situation whereby similar syndromes are caused
by many different infectious agents bears a
striking similarity with the situation of envi-
ronmental exposure to chemical agents because
many different agents or mixtures can produce
a similar syndrome. New infectious agents
(and, by analogy, chemical exposures) that pro-
duce these nonspeciﬁc syndromes may elude
detection for long periods or until such time
as a unique syndrome has been successfully
related to an agent/exposure (e.g., Escherichia
coli O157:H7c and hemolytic uremic syn-
drome). Although surveillance systems to mon-
itor entire populations for these ubiquitous
disease syndromes or symptoms that generally
do not result in chronic illness or death have
not been a priority in the past, the importance
of “syndromic surveillance” has now been rec-
ognized (CDC 2004). Only when there is a
small susceptible group that suffers severe symp-
toms or deaths do these syndromes start to draw
public attention and require a response and
investment in pathogen identiﬁcation and dis-
ease prevention efforts (e.g., the West Nile virus
outbreak; most infected individuals show minor
symptoms of respiratory illness, but some infec-
tions in the elderly cause death). In general, for
infectious diseases and syndromes for which we
lack diagnostic and/or immunization-based
prevention tools as a society, we opt for broad-
based strategies to prevent exposure and inter-
vene on potential media (e.g., prevention of
contamination of water or food by micro-
organisms), instead of implementation of large
disease- or syndrome-based surveillance.
Acute poisoning from metals or chemicals
has similar attributes to infectious diseases,
such as speciﬁc and acute symptom complexes
that can be identified via biological tests. In
the case of lead poisoning, state and federal
agencies implemented a combination of pre-
ventive measures (removing lead from paint
and gasoline) and surveillance for high levels of
exposure that are likely in susceptible groups
(e.g., in California for young low-income chil-
dren with health insurance from Medi-Cal).
However, there is one fundamental difference
compared with the treatment of an infectious
disease: Only lead removal from the envi-
ronment, not the medical treatment of an
individual, will reduce the risk to others in
contaminated environments. Thus, the inter-
vention that follows the identiﬁcation of a poi-
soning case through surveillance will have to
be broader and include remedial activities that
remove the sources of poisoning. In fact, as we
discuss below, the primary operational goal of
environmental health tracking is the “treat-
ment” of the environment in such a manner as
to reduce population risk. Although a substan-
tial part of the effort to control infectious dis-
eases would also fall under this rubric, it is
important to recognize that the individual
medical treatment and prevention aspects of
infectious disease surveillance are less relevant
for many of the noninfectious health out-
comes that will be considered for inclusion as
part of environmental health tracking (e.g.,
asthma, many cancers).
Surveillance for chronic diseases. Similar to
infectious and other acute disease surveillance,
surveillance for chronic diseases has been imple-
mented largely for diseases that are dreaded
because of their consequences (disability and
death). We deﬁne a chronic disease/syndrome
as one that can have acute or insidious onset
and whose symptoms and/or physiological
abnormalities persist over long periods of time
(years to lifelong, but they can remit with or
without recurrence, e.g., asthma).
Another criterion that applies to both
types of diseases for which surveillance sys-
tems exist is that they are identiﬁable by clini-
cal and/or pathological examination with a
high degree of specificity; that is, measure-
ment tools are available and cost-effective and
allow for unambiguous diagnosis. However,
although early disease detection and interven-
tion might be favorable and increase survival
for some chronic diseases (e.g., carcinoma of
the cervix, colon cancer, breast cancer), for
many, neither screening tools nor universally
effective treatments are available (e.g., lung
cancer, many cancers of the gastrointestinal
tract). Furthermore, because many chronic
diseases generally are irreversible without some
intervention, treatment interventions will not
remove the cause of the disease in the same
way as an antibiotic may eliminate bacteria
and, at the same time, prevent transmission of
the infection to others. However, in contrast
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the case of lead poisoning, treatment for a
chronic disease such as asthma is likely to be
effective independent of the cause of the dis-
ease; for example, inhaled steroid treatment
reduces inﬂammation and symptoms regard-
less of the nature of the trigger (molds, viruses,
or air pollution) causing attacks.
Cancer surveillance has been described by
CDC as an essential tool to a) assess patterns in
the occurrence of cancer and detect important
trends within populations, b) assess the impact
of cancer prevention programs, and c) allow
the rational allocation of limited resources for
cancer (CDC 2004). Some of the attributes
that favor certain infectious diseases for surveil-
lance activities clearly overlap with those of cer-
tain cancers; that is, for some cancer types,
effective strategies exist for reduction of mortal-
ity from cancer, and strategies for prevention of
new cases may exist that include changes in
behavioral and environmental factors.
Interestingly, another stated goal of cancer
surveillance is the “wise allocation of limited
resources including setting priorities for allo-
cating health resources,” which depends partly
on the “availability of complete, timely, and
high-quality cancer data” (CDC 2004). For
those cancers for which the etiology is unclear
and/or complex and/or for which satisfactory
early screening tools and/or treatments are
lacking, surveillance data represent an impor-
tant research tool for ascertainment of disease
etiology (host and environmental factors) and
deﬁnition of disease natural history (progress
of disease over time). For those cancers for
which screening is new (e.g., recommenda-
tions for colonoscopy for colon cancer) or for
which the groups that derive maximum bene-
ﬁt are still controversial (e.g., mammography),
surveillance can provide important data on the
effectiveness of screening. However, if there
are long lag periods between the introduction
of a screening procedure and improved sur-
vival for a speciﬁc cancer, it may be difﬁcult
to quantitate the population beneﬁt. If a new
environmental exposure or some human
behavior intervenes during this time interval
and changes the incidence and/or the natural
history of a given cancer or group of cancers,
the efficacy of a screening program may be
underestimated at best or considered nonexis-
tent at worst. These issues clearly are relevant
for any environmental health tracking system
that focuses on chronic health problems.
These issues are summarized in Table 1.
The same caveat for new screening tools
also applies to the evaluation of preventive
interventions. Because of the long latency
between initiation and diagnosis of most can-
cers, the effectiveness of preventive interven-
tions, such as the success of smoking cessation
programs, will not become apparent until
years or even decades after implementation.
Thus, intervention evaluation efforts must
operate on a different time scale from those for
many acute infectious diseases. Furthermore,
cancers, like most chronic diseases, have multi-
factorial etiologies such that several risk factors
operate through different or similar pathways
that lead to the same outcome: For example,
lung cancer can be caused by smoking and by
exposure to asbestos, and subjects exposed to
both agents may differ in risk from those
exposed to either one of these carcinogens
(Liddell 2001). However, surveillance of can-
cer trends over time that aims to document
the success of an intervention could be mis-
leading if the reduction of one of the carcino-
gens in a population (e.g., the prevalence of
asbestos exposure) is accompanied by an
increase in prevalence in another risk factor for
the disease (e.g., smoking). Whether or not
these two exposures would affect the same
individuals in a population would not matter,
because we are only monitoring trends in
overall population rates.
Although cancer surveillance through
registries enables a vast amount of etiologic
research that contributes to the identiﬁcation of
cancer risk and preventive factors, this research
is not part of the monitoring/surveillance effort
per se but requires separately funded scientiﬁc
studies, some of which will make use of sur-
veillance data as a primary or major resource.
These studies are necessary to identify the
cancer-initiating events that generally precede
disease diagnosis by years or decades and
to estimate individual level exposures and
take latency and susceptibility into account.
Etiologic factors that contribute to cancers are
not identifiable through disease surveillance
except in those rare cases where a carcinogenic
agent can be identified by a biological or
chemical marker in the affected tissue(s) long
after the initiation of cancer. One example is
the human papilloma virus, which can be
identified at higher rates in the tissue of
women diagnosed with cervical cancer than
among nonaffected controls (Salmeron et al.
2003). However in such cases, to permit
causal inferences, a registry also would need to
obtain samples from unaffected population
controls, a task outside the scope of any reg-
istry. This reasoning extends also to cancer
cluster investigations; that is, only when an
etiology is already established and highly spe-
ciﬁc (e.g., for vinyl chloride and angiosarcoma
or asbestos and mesothelioma, but not
asbestos and lung cancer) can a cluster suggest
the cause of the disease and be used to help
guide intervention and prevention efforts
(removal of asbestos). Therefore, careful con-
sideration must be given to the expenditure of
resources to investigate such occurrences.
Environmental Health Tracking
Use of existing surveillance systems for linkage
purposes. We have listed the goals and require-
ments for an EPHT system in Table 2.
Generally, such a system can take advantage of
already existing, active, passive, or sentinel sur-
veillance systems, if the requirements for link-
age are fulfilled (see “System requirements,”
Table 2) or if they can be used as a starting
point from which additional data that pertain
to environmental exposures or the diseases of
interest can be obtained. These systems have
different functions, costs, and utility for public
health and environmental tracking. Active sur-
veillance systems have the advantage of rela-
tively complete ascertainment and standardized
collection of data over time but are very resource
intensive and usually focused only on one type
of disease or exposure. Passive systems are
cheaper to maintain but are potentially subject
to biased, incomplete reporting. Reports of
unusual events (e.g., space–time clusters of dis-
ease, uncommon exposures such as a toxic
spill) do not meet the formal requirements for
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Table 1. Challenges for chronic disease surveillance relevant to EPHT.
Characteristics of the disease
Onset can be insidious
Exact time of onset not known and often not subject to estimation, which complicate temporal 
characteristics of exposure
Often long latency between onset of exposure and clinical manifestation of disease
Heterogeneous mix of phenotypic components (e.g., asthma: allergic, nonallergic, cough variant types)
May have multiple natural histories and differ in antecedent exposure proﬁles (risk factors for onset or recurrence)
Genetic heterogeneity may not be reﬂected in phenotype (e.g., young-onset breast cancers with and without BRCA1
and BRCA2 mutations)
Multiple etiologies; some pathways may not involve the same putative risk factors (e.g., young-onset Parkinson 
disease caused by MPTP exposure or by Parkin mutations)
Characteristics of exposure
Often involves complex mixtures that can change over time
Relevant parameters often not easily deﬁned
Timing of onset
Cumulative dose versus critical time of exposure
Threshold versus no threshold
Effect modiﬁcation by other exposures
Direct measurement often not available
Reliance on imperfect surrogates
MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.surveillance noted above. However, the systems
through which these reports appear (e.g.,
Morbidity and Mortality Weekly Report) do
provide the temporal continuity and standard-
ization of presentation that satisfy the require-
ments for surveillance. Reports of unusual
events may provide the initial stimulus for
the identiﬁcation of important ongoing, envi-
ronmental health risks but should avoid the
pitfalls of chronic disease (cancer) cluster inves-
tigations. Most important, all existing surveil-
lance systems, once they fulﬁll the requirements
for linkage, can serve descriptive functions and
allow the conduct of ecologic analyses in the
broadest sense—that is, population exposures
and outcomes for population inference. On the
other hand, etiologic questions may be answer-
able only if additional resources become avail-
able to a) provide for collection of additional
data for assessment of exposure and other dis-
ease risk factors (e.g., those that act as con-
founders or effect modiﬁers) at the individual
level (e.g., pesticide or air pollution exposures at
homes and workplaces of subjects of interest,
smoking and diet information, genetic suscepti-
bility factors, access to health care); b) collect
data in control subjects (e.g., nondiseased sub-
jects as controls for cancers) or collect data for
diseases for which routine monitoring systems
are not in place (e.g., asthma); and c) conduct
additional data analysis not provided for within
the routine monitoring systems. Furthermore,
certain etiologic questions may be answered
best through other types of study design that do
not rely on disease monitoring in a geographi-
cally based population but either follow cohorts
of individuals over a long time [e.g., Nurses’
Health Study (Hunter et al. 1990; Laden et al.
2001) cohort] and/or store biological samples
for a large number of individuals [e.g., the
National Health and Nutrition Examination
Survey (NHANES) (Chapman et al. 2003)], or
target special highly exposed groups within a
population [e.g., the Agricultural Health Study
for pesticide exposures (Alavanja et al. 2003)]
or vulnerable subgroups of a population (chil-
dren for asthma, elderly for Alzheimer or
Parkinson disease). Table 3 lists the advantages
and disadvantages of different systems to evalu-
ate environmental health questions and refer-
ences examples from the literature for the use
of such systems.
Criteria for the expansion/contractions of
an existing surveillance system. The design of
an EPHT and surveillance system cannot be
static. There always will be a need to expand
the “core” of the system or to provide ad hoc
elements to address specific issues whether
these relate to what data the system collect or
which populations it needs to cover. The crite-
ria for expansion (and contraction) cannot be
speciﬁed a priori; however, what can be speci-
fied is a process to keep the system dynamic
and relevant. Table 4 summarizes some sug-
gested questions that should be addressed.
Most important are recognition of the need
for continued re-evaluation and the existence
of a base of fiscal resources to make adjust-
ments when such are deemed necessary.
A parallel issue relates to the ability of a
tracking system to recognize the potential for
some new environmental exposure to cause
health effects before adequate human health
data are available. The solution to this problem
is the inclusion of a mechanism for ongoing,
continuing reviews of the relevant toxicology
and exposure literature. The regular preparation
of position papers by expert panels should serve
as the ﬁrst step in the decision-making process
that is identiﬁed by item 1 in Table 4. The ﬁnd-
ings of these position papers should be subjected
to a second-level review to assess the logistical
and cost–beneﬁt implications of the inclusion of
new exposures into the tracking system.
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Table 2. Goals and requirements for an EPHT system.
Surveillance goals Requirements for health data Requirements for exposure data System requirements
Descriptive (ecologic) Chronic diseases Long-term exposure assessment Minimum set of variables for linkage
Temporal Speciﬁcity of diagnosis Broad spatial coverage that captures is available (e.g., residential/work
Spatial Standardization of diagnostic medium-scale spatial heterogeneity and should address and geocoded exposure
algorithms over time and procedures “match” health spatial units as closely as possible location)
to convert from one standard to Long historical record keeping and acceptable Clear documentation of all variable
another (e.g., ICD-9 to ICD-10) procedures to convert old to new measurement ﬁelds, including documentation of history
Moderately short time delays techniques or metrics of changes in format and/or content
between diagnosis and “registration” Develop criteria for selection of exposures such Continued linkage of health and
(e.g., example within 6 months) as known or suspected health impacts and/or exposure data
Agreed upon spatial reference regulatory requirements Continued dissemination of results
(e.g., residence at diagnosis) Identiﬁcation of “sentinel” substances where to agencies and public
Acute diseases (e.g., poisonings) possible Ongoing administrative, legal, and
Speciﬁcity of diagnosis Collect data on ﬁscal support for linkage and
Standardization of diagnostic Broad categories of sources dissemination activities
algorithms over time and procedures Broad classes of relevant “components”
to convert from one standard to
another (e.g., ICD-9 to ICD-10)
Short time delay between
identiﬁcation and registration
(e.g., days to weeks)
Agreed upon spatial reference
(e.g., residence at diagnosis)
Etiologic Chronic and acute diseases and clusters Requirements in addition to those mentioned above Requirements in addition to those
Chronic Speciﬁcity and standardization Near real-time or real-time access to mentioned above
Acute (as needed for descriptive purposes) quality-assured data for acute disease and Ability to acquire QA/QC and
Clusters (spatial Time of registration and spatial cluster evaluation release data consistent with time
and temporal) reference (as above) Ability to estimate individual exposure for requirements
Expanded data on risk factors acute, cluster and chronic disease, or Ability to support special monitoring
Access to noncases for risk reﬁned spatial and temporal data for acute projects
factors and exposure disease and cluster evaluation Fiscal and staff support for ongoing
Data sufﬁcient for spatial and temporal modeling
(acute and cumulative) exposure modeling Fiscal support for selected, existing
over time for chronic disease registries and special studies
Speciﬁc source apportionment in terms of
sources and components for acute disease
and cluster evaluation
Abbreviations: ICD, International Classiﬁcation of Diseases, 9th and 10th Revisions (WHO 1978, 1993); QA/QC, quality assurance/quality control.Commentary | Environmental public health tracking
Environmental Health Perspectives • VOLUME 113 | NUMBER 3 | March 2005 247
Table 3. Advantages and disadvantages of various systems for the examination of environmental health questions.
Selected
Registries Advantages Disadvantages examples/references
Disease registries
Death or birth certiﬁcates Standardized continuous collection of data Outcome data are relatively limited in breadth (i.e., to Ritz et al. 2000
for the total population in a geographic area fatal diseases and few birth outcomes) Wilhelm and Ritz 2003
Collects causes of deaths, birth weight, and Relatively little quality control over data collection
gestational age in a standardized manner No exposure data
Allows examination of differences in space Automatic link to exposure data possible through
and time that includes trends for causes of address (at birth or deaths)
deaths and birth outcomes For extensive individual level exposure assessment,
Relatively cheap and well established subjects (or proxies) need to be contacted (additional
research funding necessary)
Potential ethical and legal concerns related to automatic
data linkage
Disease registries Standardized continuous collection of data Laws necessary that mandate reporting and registration Ritz et al. 2002
(reportable infectious for the total or subgroups of a population in Continuous and extensive ﬁnancial support necessary Reynolds et al. 2003
diseases, cancer, a geographic area Often registers only one speciﬁc type of disease Shaw et al. 1999
end-stage renal disease, Allows examination of differences in space and No exposure data available Mann et al. 2002
and birth defect time that includes trends for these diseases Automatic link to exposure data possible through address
registries; hospital High-data quality for registries established at diagnosis (additional research funding necessary)
discharge data; health in accordance with speciﬁed (national) Potential ethical and legal concerns related to automatic
maintenance standards (e.g., surveillance epidemiology data linkage
organization data) and end results cancer registry standards)
Exposure/hazard registries
Ecological exposure Standardized continuous collection of exposure Laws necessary that mandate reporting and registration Ritz and Yu 1999
registries/databases data for the total population in a Continuous and extensive ﬁnancial support necessary Mortimer et al. 2002
(air and water pollution, geographic area Usually registers only one speciﬁc type or group
pesticides, industrial Allows examination of differences in of exposures in a single medium (e.g., air, water)
emissions inventories) space and time that includes trends for Exposure data are collected at the ecological not
these exposures at the individual level
High-data quality for these registries based No disease information without additional linkage
upon certain speciﬁed (national) standards to geographic identiﬁers (e.g., addresses)
Allows for population-level exposure For disease outcome, linkage subjects (or proxies) may need
estimates either directly or through model to be contacted (additional research funding necessary)
Individual-level Collects speciﬁc exposure data for a group Very expensive Murphy et al. 1983
exposure registries of select individuals suspected to be Usually only one type of speciﬁc exposure collected MacIntosh et al. 1996
(biomonitoring, e.g., exposed at high levels, or for a regional or Usually no disease data collected simultaneously Ruckart et al. 2004
NHANES) national random sample of the population or prospectively (needs addition research funding)
Allows examination of exposure differences If samples are collected for speciﬁc research purposes
in space and time that includes trends for only, subjects need to consent to new analyses
exposures if collected repeatedly or continuously Groups that are willing to contribute urine, blood,
Individual-level exposure measurements available etc., may not be representative of the larger population
Speciﬁc exposures of relatively high data quality
Surveys
Cross-sectional or Collect data on one or more diseases and exposures One time or repeated high ﬁnancial investment Keil et al. 1996
repeated surveys simultaneously for a representative regional, national, necessary; costs depend on data collection protocol, Hirsch et al. 1999
(NHANES, ISAAC, or international sample using standardized methods sample size, length of observation period, etc. Ramadour et al. 2000
MONICA, CHIS) Allows examination of differences in space and time Cross-sectional data for exposure and disease may Peters et al. 2001
including trends for exposures and diseases if cause problems of temporal ambiguity and survivor bias Chapman et al. 2003
collected repeatedly Disease outcome measures often rely on self-report only
Individual-level exposure and disease measures Research subjects have to be willing to participate, thus
available may not be representative of the general population
High-data quality
Subjects need to be contacted and participate
only once
Longitudinal cohorts Collect one or more diseases and exposures Extremely high ﬁnancial investment necessary over Hunter et al. 1990
(Framingham study, over time extended periods; costs depend on data collection Garland et al. 1995
Nurses’ Health Study, Longitudinal data for exposure and disease protocol, sample size, length of observation period, etc. Feskanich et al. 1998
California Teachers avoid problems of temporal ambiguity A cohort is by deﬁnition a restricted group of Laden et al. 1999, 2001
Study, Agricultural Investigation of outcomes beyond those of individuals that may or may not be representative Alavanja et al. 2003
Health Study) original interest often can be undertaken of a population of speciﬁc interest (e.g., those
Individual-level exposure estimates available highly exposed to an environmental agent or
High-data quality those within a susceptible age or ethnicity)
Research subjects have to be willing to participate
repeatedly over extended periods of time and have
to be traceable
The study protocol dictates exactly for which disease
and exposures information will be collected, unless
biological samples can be stored for later analyses
(which may have legal implications for consent)
Abbreviations: CHIS, California Health Interview Survey; ISAAC, International Study of Asthma and Allergies in Childhood; MONICA, Monitoring of Trends and Determinants in
Cardiovascular Diseases.Conclusions and
Recommendations
Initiation of linkage between existing disease
and exposure surveillance systems for EPHT is
very desirable and feasible. We have identiﬁed
what we believe to be the important pitfalls
that should be avoided for such linkage activi-
ties. The goals, purposes, and limitations of
any proposed linkage must be discussed and
stated clearly. In addition, currently available
data resources and surveillance systems will
need to be evaluated critically first to decide
whether they fit the criteria for a successful
linkage or might need to be updated and
expanded to make linkage possible and useful.
Identiﬁcation of many important relations
between environmental factors and heath out-
comes requires individual-level data that are
not routinely collected by any surveillance
system; thus, these can be addressed ade-
quately only with targeted research. In con-
trast, data linkages performed in a surveillance
context typically will not be able to address
key factors at the level of the individual. Data
linkage efforts may be able to detect some
relations but would also be expected to miss
others that could, however, be established in
well-designed epidemiological studies. The
distinction between data linkages in the sur-
veillance context and targeted research is an
important one, and the EPHT program must
avoid the expectation that simple linkage
approaches in the surveillance context can
substitute for sound epidemiological research.
Design of surveillance approaches requires
a balance between demands for more exten-
sive and higher quality data and the feasibility
of collecting such data. For environmental
agent–disease relationships that are already
well established, formal linkage of data may
not be the most efﬁcient use of resources. For
example, exposure to lead has been clearly
associated with decreased cognitive develop-
ment in children. Use of data linkage projects
to assess this relationship at the community
level might be problematic because of our
potential inability to detect subtle but impor-
tant effects that require large cohorts of chil-
dren and very sophisticated test procedures,
and resources might be better devoted to
identifying and addressing determinants of
exposure. Furthermore, tracking of exposures
to environmental agents without linkage to
health outcomes can spawn effective inter-
ventions, such as efforts to reduce the use of
polybrominated diphenyl ethers after these
compounds were detected in increasing con-
centration over time in human breast milk.
Concerns about the implications of data
linkage are particularly important in a policy
context. A community-level association
between exposure to an environmental hazard
and an adverse health outcome need not be
demonstrated before intervention is initiated
if the relationship has been appropriately
established in the scientific literature. For
example, not every community needs to show
a relationship between consumption of local
ﬁsh contaminated with mercury and elevated
blood mercury levels before taking action to
warn the population that excessive local fish
consumption should be avoided. Moreover,
as we discussed above, for chronic diseases of
multifactorial etiology, it will be difficult to
demonstrate relationships between reductions
in releases or concentrations of environmental
agents and disease outcomes. The U.S. EPA is
beginning to emphasize “accountability”—
that is, demonstrations that reductions in
health outcomes result from policy activities
that reduce levels of hazardous agents in the
environment. Although it is laudable to show
such relationships where they can be demon-
strated, the converse view that such relation-
ships must be demonstrated before a policy
intervention can be initiated is not supported.
Because chronic, multifactorial diseases do
not lend themselves to data-driven, quick, and
convenient evaluations of intervention strate-
gies, time trends, exposure identification, or
the identiﬁcation of at-risk populations based
on linkage and surveillance only, we propose
that, ﬁrst and foremost, EPHT should be syn-
onymous with a dynamic process that requires
regular system updates to a) incorporate new
technologies to improve exposure and disease
assessment at the population level, b) allow
public dissemination of new data that become
available, c) allow the public health and envi-
ronmental policy communities to address new
and emerging “threads” (for both exposures
and health outcomes), and d) evaluate its effec-
tiveness over some appropriate time interval. A
challenge will be to maintain consistent sup-
port and funding for important routine public
health systems that may seem less exciting than
the public outrage producing “toxins or dis-
eases of the week.” This is particularly true
at times of economic downturns, in response
to short-term public and political pressures.
Although the risks attributable to environmen-
tal factors might be small in a relative sense,
they can result in a large disease burden in
absolute numbers because of the ubiquitous
nature of certain exposures, the possible syn-
ergy of these factors with other risk factors, and
the increased vulnerability of certain subpopu-
lations. Thus, risk assessments based on any
single surveillance system are likely to provide
downwardly biased estimates of risk for a spe-
ciﬁc environmental hazard, because of the dif-
ﬁculty related to the identiﬁcation of the effects
of exposures to multiple environmental hazards
whose composition may change over time and
for which it is nearly impossible to construct
accurate exposure histories even at an ecologi-
cal level. Nonetheless, in some cases, surveil-
lance may be the only practical method to
obtain sufﬁcient data to carry out a preliminary
assessment of risk (contingent on adequate
quality data).
By their nature, many chronic diseases are
irreversible to a large extent (if at all) even after
the exposure is removed. Therefore, treatment
interventions directed at individuals will not
remove the cause of the disease or the possible
source of disease for others in the community.
Thus, the primary operational goal of environ-
mental health tracking has to be the “treat-
ment” of the environment in such a manner as
to reduce population risk. It will be important
and necessary to evaluate and weigh the bene-
fits of surveillance against its costs. In addi-
tion, we have pointed out that some strategies
to evaluate the effectiveness of interventions
can be severely ﬂawed if they do not address
the complexity of disease causation. On the
other hand, prevention might be our only
rationale option, even if multifactorial diseases
do not lend themselves to surveillance data-
driven evaluations of intervention strategies.
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